nature biotechnology r e v i e w Once programmed to perform a specific function, cells rarely undergo dramatic fate changes in vivo. It was long thought that this phenotypic stability was the result of an irreversible loss of developmental potency that accompanied each progressive differentiation step in the embryo. However, the cloning of an animal from the nucleus of a terminally differentiated cell by nuclear transfer unambiguously proved that epigenetic modifications to the genome acquired during development are reversible and that nuclei from even the most functionally specialized cells maintained the potential to generate an adult organism 1-11 . Cell fusion experiments also indicated that transcriptional reprogramming could occur after exposure to the nuclear and cytoplasmic components of cells from other lineages, such as myotubes and pluripotent stem cells [12] [13] [14] [15] [16] [17] . Even so, it was difficult to decipher the mechanism of reprogramming in fused cells owing to the continuous presence of the donor cell genome.
r e v i e w Once programmed to perform a specific function, cells rarely undergo dramatic fate changes in vivo. It was long thought that this phenotypic stability was the result of an irreversible loss of developmental potency that accompanied each progressive differentiation step in the embryo. However, the cloning of an animal from the nucleus of a terminally differentiated cell by nuclear transfer unambiguously proved that epigenetic modifications to the genome acquired during development are reversible and that nuclei from even the most functionally specialized cells maintained the potential to generate an adult organism [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] . Cell fusion experiments also indicated that transcriptional reprogramming could occur after exposure to the nuclear and cytoplasmic components of cells from other lineages, such as myotubes and pluripotent stem cells [12] [13] [14] [15] [16] [17] . Even so, it was difficult to decipher the mechanism of reprogramming in fused cells owing to the continuous presence of the donor cell genome.
Substantial progress was achieved with the discovery that a combination of defined transcription factors was sufficient to reprogram diverse somatic cell types to a pluripotent state in vitro [18] [19] [20] [21] [22] [23] [24] [25] [26] . These studies raised the question of whether reprogramming to a pluripotent state was fundamentally distinct from reprogramming to defined somatic lineages (Fig. 1) . In one model, reprogramming to pluripotency represents a return to a developmental 'ground state' and is simply the result of the erasure of all developmentally acquired epigenetic information 27 . In another model, epigenetic memory is not simply erased but the epigenetic features of the target cell type are actively induced, resulting in a direct conversion of the two cell states without physiological intermediates. The first model could only explain reprogramming into more primitive cell types. The second model, however, provides a template for direct lineage conversions between distantly related cell types. Indeed-although it does not disprove the validity of the first model-earlier work, such as the classic report from Weintraub and colleagues 28 showing that the transcription factor MyoD (also known as Myod1) is capable of converting fibroblast cell lines into myocytes, and more recent findings from various cell lineages [28] [29] [30] [31] , support the notion that cell fate conversions can be direct, without the involvement of dedifferentiation, even between distantly related somatic cell types (Fig. 2) .
In this review, we discuss the latest developments in lineage reprogramming of various cell types (for excellent reviews about the history of the field, see e.g., refs. 3, 17, [32] [33] [34] [35] . Given that multiple examples of direct lineage reprogramming with transcription factors have now been published 18, [28] [29] [30] [31] [36] [37] [38] [39] [40] [41] [42] [43] [44] (Table 1) , we also summarize emerging themes and important unresolved issues in the field. From the perspective of a developmental biologist, lineage reprogramming offers exciting new experimental tools for interrogating aspects of lineage commitment and terminal differentiation processes observed during normal development. From a translational perspective, it provides a fundamentally new approach for the generation of patient-specific cells for in vitro disease modeling or direct therapeutic applications.
MyoD and the myogenic program Pioneering work by Taylor and Jones 45 demonstrated that treatment of an immortalized mouse embryonic fibroblast cell line with the DNA demethylating agent 5-azacytidine was sufficient to induce myogenic, chondrogenic and adipogenic clones. The high conversion frequencies suggested that the reactivation of a small number of loci was likely to be responsible for these lineage-conversion events. It is now known that many CpG islands that are typically unmethylated in vivo and in primary cells can readily become methylated in immortalized cell lines [46] [47] [48] . Therefore, it is possible that the effects of 5-azacytidine observed by Taylor and Jones were due to reactivation of CpG island promoters to their in vivo state.
Subsequent heterokaryon experiments by Blau and colleagues 13 , in which two somatic cell types were stably fused but maintained separate nuclei (and thus did not divide), demonstrated that myogenic factors present in myocytes could elicit expression of myocyte-specific genes from amniocytes and other cell types. Heterokaryon studies also indicated that DNA methylation was important for silencing lineage-inappropriate gene expression. For example, 5-azacytidine Direct lineage conversions: unnatural but useful?
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Classic experiments such as somatic cell nuclear transfer into oocytes and cell fusion demonstrated that differentiated cells are not irreversibly committed to their fate. More recent work has built on these conclusions and discovered defined factors that directly induce one specific cell type from another, which may be as distantly related as cells from different germ layers. This suggests the possibility that any specific cell type may be directly converted into any other if the appropriate reprogramming factors are known. Direct lineage conversion could provide important new sources of human cells for modeling disease processes or for cellular-replacement therapies. For future applications, it will be critical to carefully determine the fidelity of reprogramming and to develop methods for robustly and efficiently generating human cell types of interest. r e v i e w treatment before myotube fusion was required for the induction of muscle-specific gene expression from HeLa cell nuclei 49 .
These observations led Weintraub and colleagues 28 to screen cDNA libraries from 5-azacytidine-induced myogenic clones for factors that could explain the myogenic effects of 5-azacytidine treatments. This resulted in the discovery of the gene MyoD, which encodes a basic helix-loop-helix transcription factor that can induce expression of myogenic markers in various fibroblast and adipose cell lines 28, 50 . Importantly, forced expression of MyoD could convert primary mouse dermal fibroblasts into myocytes, whereas 5-azacytidine treatment could induce myogenic differentiation only in immortalized cell lines 50, 51 . These findings provided the first evidence that the intrinsic activity of a single gene was sufficient to drive lineage-specific differentiation programs in a lineage-independent manner 28, 50, 52, 53 .
Further studies confirmed that forced expression of MyoD induced expression of skeletal muscle-specific genes (that is, desmin and myosin heavy chain) in a variety of cell types in vitro, including melanoma, neuroblastoma, liver, retinal pigmented epithelia and adipose-derived cell lines 50, 51 . However, only mesodermal cell types appeared to complete a full phenotypic switch, whereas endodermal and ectodermal cells generally did not downregulate expression of their tissue-specific genes 50, 54 . Similarly, work using heterokaryons indicated that trans-acting factors present in muscle cells could induce muscle-specific genes in cells derived from all three germ layers, although ectodermal and endodermal cells exhibited slower kinetics of muscle gene activation 14, 55 . In general, cell fusion appeared to be more powerful at inducing myogenic programs than transcription factors alone. For example, forced expression of MyoD in the MRC5 human fetal lung fibroblast line was not sufficient to activate myosin heavy chain expression; however, when stable heterokaryons were produced between MRC5 cells and muscle cells, myosin heavy chain expression was readily detectable 54, 56 . These data suggested that trans acting factors other than MyoD were important for regulating transcription of muscle-specific genes from nonmuscle cells [57] [58] [59] .
Later work identified three additional myogenic basic helixloop-helix factors (Myf5, Mrf4 (also known as Myf6) and Myog (myogenin)) that regulate partially overlapping but distinct processes during the development of skeletal muscle 60 . MyoD and Myf5 are both sufficient but not essential for myogenesis, whereas Mrf4 (ref. 61) and Myog seem to act downstream of these factors to regulate terminal differentiation processes [62] [63] [64] [65] [66] . MyoD and Myf5 share a histidine-and cysteine-rich domain and a C-terminal amphipathic α-helix (helix III domain) that is different from the other myogenic basic helix-loop-helix factors. These two domains are not required for transcriptional activation and instead appear to be important for the recruitment of chromatin-remodeling proteins to a specific subset of MyoD target genes (including the Myog promoter) that are bound by Pbx proteins before MyoD recruitment 67 . These unique features could facilitate the activation of genes in heterochromatin by recruiting SWI/SNF chromatin-remodeling complexes or histone acetyltransferases to a specific subset of MyoD target genes or tissue-specific enhancer elements 68 , which is likely important for imparting their specification functions during development 69 . r e v i e w
The discovery that a single transcription factor can be sufficient to activate lineage-specific genes outside of its normal cellular context raised important questions about the basic biology of cellular differentiation, some of which have been studied intensively over the past 25 years and some of which are only beginning to be addressed. For example, how does MyoD find its physiologically relevant binding sites in heterochomatic regions of the genome? Similarly, how does the expression of a single gene recapitulate the temporal patterns of gene expression found during normal muscle differentiation 65 ? Genome-scale studies of gene expression and transcription factor occupancy during muscle differentiation have begun to provide insight into these issues. Chromatin immunoprecipitation sequencing (ChIP-Seq) of MyoD in muscle cells and in fibroblasts expressing MyoD indicated not only that this transcription factor binds to the promoters of many genes that regulate muscle differentiation at early and late stages but also that its binding is correlated with acetylated histones genome-wide 70 . Paradoxically, MyoD was also shown to bind constitutively to thousands of other genomic regions, independent of differentiation status. These results suggest that additional factors likely contribute to gene-specific regulation at MyoD-bound promoters and enhancers. Along these lines, a key question will be to elucidate the mechanisms that regulate the temporal activation of genes controlled by MyoD (as well as the other myogenic basic helix-loop-helix factors), which is likely to involve MyoD-associated cofactors (e.g., Mef2 family proteins, Pbx/Meis family proteins, p38 MAPK, PCAF and p300, among others) 67, 71, 72 , chromatin-remodeling complexes 73, 74 and the cis-regulatory organization of the promoters of MyoD-regulated genes, including the pre-existing, developmentally regulated chromatin marks at these promoters 57, 65, 68 . These studies provide an important paradigm for the reprogramming field, and continue to be particularly relevant given the demonstrated importance of other basic helix-loop-helix family transcription factors in lineage specification, terminal differentiation and lineage reprogramming (see below).
The fact that 5-azacytidine treatment of immortalized fibroblasts can also induce adipogenic differentiation has received less attention 45 . Building on this work, Spiegelman and colleagues 75 recently made the surprising discovery that Myf5-expressing muscle precursors can give rise to brown fat tissue in vivo. The transcription factor PRDM16 plays a critical role in this developmental decision by co-regulating transcriptional programs of adipogenesis through its interaction with peroxisome proliferator-activated receptor gamma (PPAR-γ), another important adipogenic determinant 76 . When expressed in primary mouse myoblasts, PRDM16 induces brown fat differentiation with nearly 100% efficiency, and when PRDM16 expression is reduced, primary brown fat cells inappropriately express skeletal muscle lineage genes such as MyoD and Myog and exhibit a myotube-like morphology 75 . However, unlike the myogenic basic helix-loop-helix factors, forced expression of PRDM16 is not sufficient to induce brown fat differentiation in nonmyogenic fibroblast cell lines. Using an unbiased proteomics approach to search for potential PRDM16 interaction partners, the authors identified C/EBP-β as a PRDM16 binding partner and found that it also exhibits highly specific expression in brown versus white adipose tissue. Strikingly, forced co-expression of PRDM16 and C/EBP-β was sufficient to convert mouse and human dermal fibroblasts into functional brown fat-like cells 77 . The reprogrammed brown fat-like cells could form fat pads and function in glucose uptake after transplantation of transduced fibroblasts into adult mice. These elegant studies highlight the power of proteomic approaches for discovering novel, biologically relevant interactions between transcription factors, a strategy that should prove similarly informative for lineage reprogramming studies in other tissues.
Induction of cardiac muscle phenotypes
Extensive developmental studies have failed to identify a single 'master regulator' of cardiac muscle fate analogous to the myogenic basic helix-loop-helix genes. Instead, cardiac development appears to be controlled by a highly conserved core module of transcription factors (Gata4, Tbx5 and Mef2c, along with Nk2 and Hand family transcription factors) that regulate cardiac specification, morphogenesis and terminal differentiation 78, 79 . Transient transfection of small groups of these core regulators into cultured early-stage mouse embryos (embryonic day (E)6.5-E8.75) provided the first evidence in mammals that reprogramming of noncardiogenic mesoderm toward a cardiac fate was possible 41 . Notably, the combination of Gata4, Tbx5 and the chromatin-remodeling protein Baf60c (also known as Smarcd3) was sufficient to precociously induce ectopic beating cardiomyocytes in the posterior mesoderm and the extra-embryonic amniotic tissue, whereas during normal development, cardiomyocytes are generated in the lateral mesoderm 78, 79 . However, these factors were not sufficient to induce cardiomyocyte differentiation during later stages of development or from cultured embryonic fibroblasts. r e v i e w
The combination of Baf60c and Gata4 was sufficient to induce the expression of some early cardiac markers, as well as other crucial regulators of cardiac development (Nkx2-5); however, ectopic Tbx5 expression was essential for the generation of beating heart tissue. Baf60c expression was necessary for Gata4 to bind at least a subset of its target genes, suggesting that tissue-specific, chromatin-remodeling events might be required for the activity of these cardiogenic transcription factors when they are expressed outside of their normal embryonic milieu. Accordingly, Baf60c is selectively expressed in the precardiac mesoderm during heart development, and loss-of-function studies in mouse indicate that it is essential for proper heart morphogenesis and for terminal differentiation of cardiac tissues 80 . Furthermore, in vitro assays indicated that Baf60c promotes a physical interaction between Tbx5, Gata4, Nkx2-5 and Brg1 (ref. 80 ), suggesting that SWI/SNF chromatin-remodeling complexes containing Brg1 and Baf60c might play a crucial role in regulating cardiac development. It is also interesting to note that there is evidence that Gata4 can function as a 'pioneer' transcription factor, meaning that it can bind to its target sites in the genome even when they are in tightly packed nucleosomes in heterochromatin 81, 82 . During liver development, Gata4 is one of the first proteins to bind to the albumin enhancer, where it might participate in creating a chromatin environment that allows other enhancer-binding transcription factors to access their target sites 81 .
Recently, Srivastava and colleagues 42 demonstrated direct conversion of mouse cardiac and dermal fibroblasts into cardiomyocyte-like cells (termed induced cardiomyocytes, or iCMs) by forced expression of three transcription factor genes (Gata4, Mef2c and Tbx5). To identify potential reprogramming factors, they chose to focus on genes that cause clear developmental defects in cardiac tissue when mutated in mice and that are also expressed at high levels in cardiomyocytes compared with cardiac fibroblasts 33, 36 . They used an iterative process of elimination to define a minimal pool of three genes (Gata4, Mef2c and Tbx5) that were sufficient to induce rapid and efficient activation of early cardiomyocyte markers, with kinetics and efficiencies similar to those seen in previous examples of lineage reprogramming in other tissues 29, 36 . In contrast to parental fibroblasts, iCMs exhibited genome-wide expression patterns that were statistically closer, but not identical, to those of neonatal cardiomyocytes, indicating that the cardiac fibroblasts underwent global transcriptional reprogramming. The authors also noted evidence of concomitant epigenetic reprogramming by comparing active and repressive histone methylation marks and DNA methylation at a small set of cardiac-specific genes. Trimethylated-H3K27 was slightly increased at these promoters in tail tip-derived iCMs compared with cardiac fibroblast-derived iCMs, suggesting that the tail tip fibroblasts were more refractory to epigenetic reprogramming. It will be interesting to compare these active and repressive epigenetic marks genome-wide in iCMs from tail tip and cardiac fibroblasts to gain a more comprehensive understanding of the epigenetic reprogramming process. Notably, electrophysiological assays of individual iCMs provided evidence of functional properties similar to those of ventricular cardiomyocytes, and a low percentage of iCMs contracted spontaneously. It will be important to explore whether protocols can be developed to more efficiently generate functional iCMs and whether other types of cardiomyocytes, such as cardiomyocytes of the atrium or sinus node, can be generated directly from fibroblasts.
The three identified transcription factors Gata4, Tbx5 and Mef2c are well-known players in cardiac development that act as a core regulatory module. This transcriptional module is stably maintained by extensive cross-regulation and auto-regulation among the component transcription factors 78 . Interestingly, genetic lineage-tracing methods provided compelling evidence that the fibroblast-to-iCM conversion occurred directly, without passing through a cardiac progenitor-like state, as critical markers of cardiac progenitors (Islet1 and Mesp1) were not activated during reprogramming 42 . This suggests that these transcription factors drive a transcriptional program of cardiomyocyte terminal differentiation in fibroblasts 83 , rather than initiating dedifferentiation of fibroblasts to a cardiac precursor state and recapitulating the entire program of heart development. This would be consistent with a feed-forward model of cardiac differentiation, in which the transcription factors that are critical for early cardiogenesis are also important for the activation and regulation of genes that control terminal cardiomyocyte differentiation, although genome-wide occupancy studies of these genes during the reprogramming process will be necessary to confirm that their binding patterns during reprogramming are similar to those found during development. Furthermore, given that reprogramming of mesodermal tissue to a cardiac fate has now been accomplished in two different contexts, it will be interesting to investigate why the genes that are sufficient for cardiac reprogramming in embryonic mesoderm cannot reprogram postnatal fibroblasts, and, conversely, what effect the three-gene cocktail identified by Srivastava and colleagues would have when transfected into embryonic mesodermal tissue. An important area of future study will be to determine whether any combination of these factors can induce iCMs from more distantly related cell types, such as ectodermal or endodermal cells.
Reprogramming blood cells
The hematopoietic system is arguably the most thoroughly characterized cellular differentiation system in mammals 84, 85 . All blood cells are derived from long-term hematopoietic stem cells, functionally defined as cells that can reconstitute a mouse's blood system and can be serially passaged into other recipients. Given its analytical power, it is not surprising that the blood system provided one of the first clear demonstrations of direct lineage conversion (see ref. 34 for an excellent review).
Although 'lineage infidelities' such as immunoglobulin or T-cell receptor gene rearrangements had been observed in some cases of myeloid leukemia, it was unclear whether this phenomenon was unique to transformed cells [86] [87] [88] . Overexpression and genetic lossof-function studies aiming to decipher the mechanisms regulating normal hematopoietic differentiation identified various transcription factors and cytokine signaling pathways as instructive lineage-determining factors 34 . For example, forced expression of the zinc-finger transcription factor GATA1, which is required for erythroid development [89] [90] [91] [92] , was sufficient to induce erythroid and megakaryocytic markers in monocytic cell lines 93, 94 . Conversely, forced expression of the ETS-domain transcription factor Sfpi1 (also known as PU.1), a critical regulator of myeloid and B-cell development, was shown to repress GATA1 expression and upregulate monocytic markers in an erythroid-megakaryocytic cell line 95 . Much of this early work used established cell lines with restricted differentiation potential, and thus the significance of the findings was initially unclear. However, subsequent studies demonstrated that forced expression of GATA1 in freshly isolated granulocyte-macrophage progenitors was sufficient to induce erythroid cell types 96 .
Transdetermination of primary cells had also been observed following alterations in cytokine signaling pathways. In attempts to test whether interleukin 2 (IL-2) signaling regulates natural killer cell differentiation, Weissman and colleagues 97 observed that primary common lymphoid progenitors isolated from human IL-2 receptor β-chain r e v i e w transgenic mice and stimulated with human IL-2 in vitro gave rise to granulocytic and monocytic lineages. The same effects were seen with pro-T-cell progenitors, but not with pro-B-cell progenitors. However, when the cells were cultured before transduction (and thus more differentiated), transdetermination did not occur. These results were surprising as the primary role of cytokines in hematopoiesis was thought to be the regulation of survival and growth of specific blood cell lineages as opposed to instructive functions. It is interesting to note that ectopic activation of the erythropoietin or IL-7 receptors, both of which have downstream signaling effects very similar to those of human IL-2R, cannot induce granulocytic and monocytic lineages in primary common lymphoid progenitors 97 . However, the receptor for granulocyte-monocyte colony stimulating factor (GM-CSF) mimics the effects of human IL-2R signaling, suggesting that upregulation of GM-CSF receptors during hematopoietic stem cell differentiation is one of the key factors regulating common lymphoid versus myeloid progenitor cell determination. Thus, it is possible that in unique cellular differentiation contexts (such as the differentiating HSC), certain signaling pathways can instruct specific lineages, but the effects of their ectopic activation may be limited to the induction of lineages sharing the same immediate progenitor cell.
Transdetermination has also been induced in different lineages of blood progenitor cells by deletion of transcription factors. For example, deletion of the B-cell determination factor Pax5 in pro-B cells can promote robust differentiation into the T-cell lineage 98, 99 . T-cell reconstitution was also observed in vivo when Pax5 was deleted in mature B cells 100 . The reconstitution potential of these reprogrammed T cells was determined by isolating Pax5-deficient B cells (CD19 + , IgM + , IgD + ) and transplanting them into lymphocyte-deficient RAG2 mice. The appearance of donor pro-B cells and the gradual development of donor-derived T cells indicated that loss of Pax5 led to dedifferentiation of mature B cells rather than a direct conversion of B into T cells. Further evidence for this conclusion is the observation that donor pro-B cells isolated from these mice could give rise to macrophages when cultured in appropriate conditions. The dedifferentiation efficiency seemed very low, however, as converted T cells were oligoclonal, and the process was highly dependent on the continued expression of Bcl2, indicating that apoptotic signals were also induced after loss of Pax5 (ref. 100) .
Work by Graf and colleagues 38 has provided clear evidence that direct conversion can occur between two mature cell types in the hematopoietic system. They demonstrated that forced expression of the basic leucine zipper transcription factors CCAAT/enhancer binding protein (C/EBP)α or β efficiently induced the macrophage marker Mac1 in primary bone marrow or spleen B cells within 4 days 38 . The B cell-derived, Mac1 + cells downregulated seven of the eight B-cell genes analyzed, upregulated five macrophage markers and failed to express granulocytic markers. The reprogrammed Mac1 + cells also exhibited concomitant morphological changes as well as the capacity to phagocytose fluorescent beads, indicating that they had acquired functional properties normally attributed to macrophages. Interestingly, the downregulation of B-cell markers was shown to be Pax5-dependent, perhaps resulting from a direct interaction with C/EBPα at the CD19 promoter 38 . Conversely, the activation of macrophage markers was dependent on PU.1 but not on the downregulation of B-cell markers, and the conversion efficiencies were increased when C/EBPα and PU.1 were both expressed. Later work demonstrated that the combination of those two genes was sufficient to induce macrophage-like cells from primary fibroblasts and from an immortalized fibroblast line (NIH3T3) 37, 38 . However, these induced macrophages were dependent upon continued expression of the exogenous factors, indicating that the factors were not sufficient to induce a stable phenotypic conversion.
Genome-scale studies of PU.1 occupancy in macrophages and fibroblasts ectopically expressing PU.1 have provided an initial insight into the potential mechanisms underlying fibroblastto-macrophage reprogramming [101] [102] [103] . The distributions of PU.1, p300 and H3K4me1 occupancy suggest that PU.1 is associated with active enhancer elements in macrophages, and that PU.1 binding at these gene-distal regulatory elements appears to be important for tissue-specific inflammatory responses following lipopolysaccharide stimulation. When PU.1 is expressed in fibroblasts, preliminary evidence suggests that it can activate these macrophage enhancer elements (measured by H3K4me1 enrichment) 102 . Furthermore, PU.1 occupancy at enhancers tends to be associated with motifs of other lineage-determining transcription factors, both in macrophages (C/EBP, AP-1) and in B-cells (E2A, EBF, Oct and NF-κB) 101 . This is consistent with a model of direct conversion in which PU.1 and C/EBPα bind to macrophage enhancer elements in fibroblasts and synergistically facilitate their activation (most likely through direct or indirect recruitment of p300). Once activated, these enhancers would then promote macrophage-specific transcriptional programs genome-wide, potentially by mediating cell type-specific, enhancerpromoter interactions 103 . Given that enhancer activity appears to be highly cell-type specific 104, 105 , transcription factors that bind active enhancers in a tissue-specific fashion would be prime candidates for lineage reprogramming. The recent identification of increasingly detailed chromatin signatures of active and 'poised' enhancers should permit more detailed studies of their roles during lineage reprogramming 106, 107 .
Graf and colleagues 108 have further examined the mechanistic aspects of B-cell-to-macrophage conversion by using a drug-inducible C/EBPα−ER (estrogen receptor) fusion protein in a permissive B-cell line. This system allows for temporally regulated direct conversion of B cells into macrophages with an efficiency of nearly 100% over a 2-to 3-day period. As early as 3 hours after C/EBPα induction, bidirectional expression changes of ~2,400 genes were observed. Time-lapse microscopy indicated that the first morphological changes occurred within 10 hours. Forced expression of C/EBPα for 48 hours was sufficient to induce a stable macrophage phenotype, and most expression changes appeared to be independent of protein synthesis, suggesting that they are caused directly by the activity of C/EBPα 108 . This defined system should provide considerable insights into the transcriptional mechanisms that facilitate direct lineage reprogramming, especially at the earliest stages after activation of reprogramming factors.
A recent study reported the induction of several traits of multipotent blood progenitors in human dermal fibroblasts 43 . The resulting cells were capable of generating cells expressing markers of granulocytic, monocytic, megakaryocytic and erythroid lineages. The induction of hematopoietic lineage markers was achieved by expression of the pluripotency and tumor-promoting gene Oct4 (ref. 109 ) in combination with a permissive culture environment. This result is unexpected because Oct4 is an important transcription factor regulating pluripotency but is not expressed in the hematopoietic system 110 . Future studies may resolve this conundrum by addressing whether Oct4 is mimicking other Pou-domain-containing transcription factors, such as Oct1 or Oct2, which are expressed in hematopoietic cells [111] [112] [113] or whether Oct4 may induce some partially reprogrammed induced pluripotent stem (iPS) cells that can subsequently be differentiated into blood lineages with the assistance of growth factor and cytokine signaling provided by the culture media. r e v i e w Reprogramming endodermal lineages Given the clinical interest in insulin-producing beta cells, numerous studies have focused on characterizing the gene regulatory networks controlling the development of the early endoderm and endocrine pancreatic tissues [114] [115] [116] [117] [118] . Notably, gene knockout, overexpression and lineage-tracing studies have provided evidence of plasticity during the development of the hepatic and pancreatic lineages 115, [119] [120] [121] [122] [123] [124] . These data have fueled many studies attempting to recapitulate this lineage plasticity by forced expression of lineage-determining transcription factors. In the following we will discuss the role of these reprogramming factors during development and speculate on the specific properties that might differentiate these genes from other important developmental regulators.
C/EBPβ was one of the first transcription factors found to be involved in lineage conversion of endodermal tissue 125 . This basic leucine zipper transcription factor is expressed during differentiation of adipose tissue and liver and, as described above, is also involved in the ectopic induction of brown fat and macrophage fates 34, 77 . Slack and colleagues 125 observed that C/EBPβ was sufficient to mimic the effects of the synthetic glucocorticoid dexamethasone and induce hepatic properties in pancreatic exocrine cells, both in immortalized cell lines and cultured primary pancreatic buds from E11.5 mouse embryos. This conversion could occur in the absence of cell division and was blocked by a dominant negative form of C/EBPβ.
Ectopic expression of the homeobox-containing transcription factor Pdx1 can induce expression of insulin and other pancreatic genes in a variety of endoderm-derived cells, including adult mouse liver [126] [127] [128] , cultured human liver cells 129, 130 and chick embryonic endoderm 131 . Pdx1 has been proposed to function as a selector gene for pancreatic development, as its expression is the first marker of pancreatic specification from the foregut endoderm 132 . In the absence of Pdx1 expression, the ventral pancreas fails to form, and the dorsal pancreas has a severe growth defect 133 . In addition, Pdx1 appears to have a later function in glucose homeostasis in mature beta cells 134 , perhaps by transactivating genes that are important for glucose sensing and metabolism, such as insulin and Glut2 (also known as Slc2a2; refs. 135, 136) . Pdx1 is expressed in the earliest pancreatic progenitors as well as in mature endocrine cells, suggesting that the later role of Pdx1 might be more relevant for its ability to induce insulin expression and other beta cell-specific features.
Proneural basic helix-loop-helix transcription factors are also involved in cell fate decisions during pancreatic development. For example, forced expression of Ngn3 can initiate endocrine differentiation in early chick endoderm, but it generates glucagon-and somatostatin-expressing cells and is insufficient to induce insulin expression in the early gut epithelium 131 . Notably, Pdx1 expression was also insufficient to induce insulin transcription in this assay 131 . On the other hand, forced expression of Ngn3 in the early pancreatic anlagen causes precocious differentiation of endocrine cells 137 . In the adult liver, it can instruct hepatic progenitor cells to differentiate into pancreatic islet tissue 138 . In embryonic endoderm, Ngn3 specifically regulates development of the endocrine lineages of the pancreas 132 in combination with components of the notch-signaling pathway 137 , whereas its expression is used as a putative marker of islet precursor cells in the mature organ 139 . In the absence of Ngn3, there is a complete loss of the endocrine lineages of the pancreas and intestine, with a corresponding loss of expression of crucial genes downstream of Ngn3 that regulate beta-cell development, such as Neurod1, Isl1 and Pax4 (ref. 140 ). In mice, there is some evidence that Ngn3 expression is maintained in adult beta cells, and that conditional loss of Ngn3 can slightly impair beta-cell function in the adult animal 141 , although further studies are needed to determine the exact function of Ngn3 in the adult pancreas 142, 143 .
Similarly, recent data indicate that Neurod1 might also be important for the proper function of terminally differentiated beta cells, indicating that it might have a distinct function in later beta-cell development 144 . In adult mouse liver, expression of Neurod1 in combination with Bct (betacellulin) can induce formation of islet-like structures that contain cells resembling all of the major endocrine cells of the islet 145 , indicating that Neurod1 alone does not specify beta-cell fate and is instead a general regulator of endocrine lineages in the pancreas. It is interesting to note that both Neurod1 and Ngn3 are also expressed during central nervous system development, suggesting that they are likely to interact with different tissue-specific co-factors during the development of these disparate lineages 146 .
MafA is a basic leucine zipper transcription factor that is specifically expressed in islet beta cells and directly activates insulin transcription by binding to a conserved cis-regulatory element in the insulin promoter [147] [148] [149] . In contrast to Ngn3 and Pdx1, in ovo electroporation of MafA into embryonic endoderm is sufficient for induction of insulin expression 131, 150 . Induction of insulin expression in a pancreatic alpha-cell line was also observed following transfection of MafA 151 . However, when MafA was prematurely expressed under the control of the Pdx1 promoter in early pancreatic epithelium, it caused severe growth defects, possibly due to an increase in cell cycle exit in progenitors, and did not lead to a relative increase in beta-cell specification 152 . Loss of MafA leads to a diabetic phenotype owing to impaired glucose-stimulated insulin secretion but does not impair the initial specification of beta cells, indicating that it is only essential for later stages of beta-cell function 151 . Unlike Pdx1 and Ngn3, MafA's initial expression coincides with the terminal differentiation of beta cells at E13. 5 (refs. 153,154) .
Major breakthroughs in attempts to ectopically induce insulinproducing cells were achieved when these master regulators of pancreatic development were combined. Of note, the combination of MafA, Pdx1 and Neurod1 synergistically increased insulin expression in the liver in vivo and ameliorated glucose tolerance in a streptozotocin-induced mouse model of diabetes mellitus 155 . Melton and colleagues 36 used an unbiased, systematic approach to identify transcription factor combinations that could convert pancreatic exocrine cells (acinar cells) into insulin-producing beta cells in vivo. Of the 20 transcription factor genes that are expressed in pancreatic endocrine progenitors or mature beta cells 114 , the 9 genes that exhibited defects in beta-cell specification or differentiation when deleted in mice were studied. All nine factors were directly introduced into the adult pancreas with adenoviral vectors. One month after viral injection, insulin-expressing cells were observed at ectopic sites throughout the pancreas. After eliminating the genes that were not required for this effect, Melton and colleagues 36 found that the combination of Pdx1, Ngn3 (or Neurod1) and MafA was sufficient to convert exocrine cells into functional beta-like cells with high efficiency (>20% of coinfected cells). The conversion process was rapid, with the first signs of insulin expression appearing after only 3 days; it could occur in the absence of cell division; and it seemed to be stable over a period of months in the absence of transgene expression. Importantly, the induced beta cells secreted insulin, recruited vasculature and rescued streptozotocin-induced hyperglycemia in adult animals, demonstrating that the reprogrammed cells had acquired functional properties. Lineage-tracing analysis using a mouse strain expressing CreERT2 under the control of a mature acinar cell-specific promoter (Cpa1) confirmed that the induced beta cells were derived from terminally differentiated exocrine cells. Interestingly, attempts by the authors to r e v i e w reprogram skeletal muscle (in vivo) and mouse embryonic fibroblasts (in vitro) using Pdx1, Ngn3 and MafA were unsuccessful.
It is noteworthy that Pdx1 and Neurod1 function not only during the development (that is, specification stages) of endocrine lineages but also in the continued maintenance of proper function in mature beta cells. Similar to the situation in the heart and hematopoietic systems, this suggests that these genes act in a feed-forward manner to control the development of beta cells. This raises the question of the relative contribution of 'specification' versus 'maintenance' functions of reprogramming factors. Furthermore, it will be interesting to determine whether factors that are normally involved in tissue specification (that is, selector genes) are critical for establishing an appropriate chromatin context for reprogramming factors to be fully functional. This could be addressed if the specification and differentiation functions of Pdx1 could be functionally separated, similar to the functional differences that underlie specification competence of MyoD/Myf5 compared to Myog. In this regard, it might be equally informative to pay careful attention to the genes that are known to be critical regulators of organ development but are not required to induce lineage conversion 36, 117 . How do these genes differ from those that are competent to induce lineage reprogramming? Genome-wide location studies may begin to shed light on this question by determining the degree of co-regulation of various sets of target genes throughout different stages of endoderm development. This would also allow for detailed studies of the cis-regulatory logic of individual sets of promoters and enhancers that are co-regulated by these genes (e.g., the insulin promoter).
Recently, two groups have demonstrated the conversion of mouse fibroblasts to hepatocyte-like cells by forced expression of Gata4, Hnf1α and Foxa3 and inactivation of p19 Arf (ref. 31) or by forced expression of Hnf4α and Foxa1, Foxa2 or Foxa3 (ref. 44 ). These hepatocyte-like cells exhibited global transcriptional reprogramming, expressed mature hepatocyte-specific markers, engrafted into the adult liver and increased survival in a genetic model of liver failure. However, they showed important differences in gene expression compared with primary hepatocytes and could only partially rescue liver function in the transplantation model. It is also interesting to note that Gata4 is one of the three factors used to convert fibroblasts to cardiomyocytes, and both Gata4 and Foxa3 are thought to be capable of acting as 'pioneer' factors during liver development 81 .
Inducing neurons
Numerous studies have characterized the critical molecular pathways underlying the diversification of cell types in the developing nervous system (reviewed in refs. [156] [157] [158] [159] [160] [161] [162] . The discovery and characterization of the proneural basic helix-loop-helix genes ignited interest in their roles during neural development, given their obvious similarity to the master regulator MyoD 146, 163, 164 . Comparisons to MyoD seemed justified, as under certain circumstances proneural basic helix-loop-helix genes could induce expression of neuronal markers in non-neural cells in vivo [165] [166] [167] [168] [169] and in vitro 170 . Of particular interest, ectopic expression of Ngn1 in the dermomyotome in vivo, as well as in cultured chick embryonic fibroblasts, induced the expression of a variety of panneural markers and immature neuronal morphologies in these mesodermal cells 168 . However, there was no further validation that the cells had acquired any of the functional properties of neurons.
Another basic helix-loop-helix gene, Ascl1, is a master regulator of neural development. Ascl1 controls neuronal versus glial specification from multipotential stem cells of the central and peripheral nervous systems 171, 172 , balances progenitor self-renewal and neuronal differentiation by promoting intercellular notch signaling 173 , and influences neuronal subtype specification processes in a context-dependent manner [174] [175] [176] . In the mammalian forebrain, Ascl1 is expressed primarily in the proliferative progenitors in the ventricular zone of the ventral telencephalon, where it promotes differentiation of γ-aminobutyric acid (GABA)ergic neurons 174 , whereas in the peripheral nervous system, it is involved in the generation of autonomic neurons 177 . These and other findings strongly suggest that proneural genes depend on specific cofactors to generate different types of neural cells in different contexts 178, 179 . Consistent with this idea, Ascl1 knockout mice show dramatic defects in neural differentiation in the olfactory epithelium and in the sympathetic, parasympathetic and enteric ganglia 180 . Ascl1 also appears to be important for the proper development of the oligodendrocyte lineage [181] [182] [183] [184] . Forced expression of Ascl1 in adult hippocampal progenitors in the dentate gyrus can promote oligodendrocyte differentiation at the expense of neuronal differentiation 185 . However, if these cells were first cultured in vitro, Ascl1 expression resulted primarily in neuronal differentiation 185 , again highlighting the context-specific function of this gene.
The potential for plasticity in neural cells in vitro became apparent after careful studies elucidated the normal developmental potential of some of the numerous neural stem/precursor cells in vivo 186 . Kondo and Raff 187 demonstrated that the well-characterized oligodendrocyte/type 2 astrocyte (O2A) precursor cells could dedifferentiate to a multipotential neural stem cell state after sequential exposure to serum (or bone morphogenetic proteins) and basic fibroblast growth factor. Building upon the discovery that radial glial cells in the developing rodent brain give rise to neurons 188, 189 , Götz and colleagues 40 attempted to determine whether more differentiated glial cells could also be instructed to differentiate into neurons. Indeed, in a candidate gene approach they found that Pax6 could induce neuronal markers in postnatal astrocytes. Follow-up studies indicated that Ascl1, Ngn2 and Dlx2 could robustly convert neonatal astrocytes into neuronal cells that were capable of generating action potentials and forming functional synapses, although Ascl1 alone was not capable of producing fully functional neurons 39, 190 . Time-lapse imaging studies showed that cell division occurred in some cases but was not a requirement for this neuronal conversion, providing strong evidence that the cells underwent a direct fate switch. Furthermore, genetic lineage tracing demonstrated that these induced neurons were derived from GLAST (l-glutamate/l-aspartate transporter)-expressing astroglia 186 . However, given that radial glia and adult neural stem cells share essentially all known markers with astrocytes, including GLAST 191 , it is currently impossible to formally prove that terminally differentiated astrocytes were the source of induced neurons.
Consistent with their roles during development, these astrocytederived, induced neuronal cells exhibited different neurotransmitter phenotypes depending on which genes were used for reprogramming. Ngn2-induced neurons from mouse and rat astrocytes exhibited markers and functional properties consistent with their acquisition of an excitatory, glutamatergic fate, whereas Dlx2-induced cells (with or without Ascl1 expression) exhibited functional and molecular properties of GABAergic neurons 39, 192 . These results are consistent with the well-described role of Dlx2 as an important determinant of neuronal fate in the ventral telencephalon downstream of Ascl1, with loss of Dlx1/2 causing Ascl1-expressing interneuron/oligodendrocyte progenitors to develop exclusively as oligodendrocytes 184 . Thus, the reprogramming process seems to recapitulate some of the same general principles of normal neuronal development 146, 160, 161 . The fact that cell division is not required for this epigenetic reprogramming to occur suggests the possibility that transcription factors might also r e v i e w be capable of reprogramming one neuronal subtype into another 193 . In fact, there is accumulating evidence suggesting that this is possible in vivo, although it has yet to be shown with neurons at later stages of development [194] [195] [196] .
To determine whether lineage reprogramming might be possible between more distantly related lineages, our group 29 set out to determine whether forced expression of critical neural lineage-determining transcription factors would be sufficient to directly convert fibroblasts into neurons. Starting from a pool of 19 genes, we observed that transduction of Ascl1 was sufficient to induce some neuronal traits in fibroblasts, such as expression of pan-neuronal proteins and immature active membrane properties. We then added each of the remaining 18 genes one at a time to screen for additional factors that could induce expression of neuronal markers in combination with Ascl1. This ultimately led to the identification of a pool of three genes, Ascl1, Brn2 and Myt1l, that was sufficient to directly reprogram embryonic and postnatal fibroblasts into functional neurons, which we called induced neuronal (iN) cells. Importantly, these iN cells were capable of firing repeated action potentials and forming functional synapses with mouse cortical neurons and with each other in vitro. Electrophysiological recordings from iN cells co-cultured with primary astrocytes showed that only excitatory postsynaptic potentials could be recorded, providing functional proof that a large majority, if not all, iN cells exhibited a glutamatergic phenotype. At earlier time points, rare cells expressing some markers of GABAergic differentiation, such as GABA and GAD67, were detected, which suggests that it might be possible to generate both functional glutamatergic and GABAergic neurons, and that our culture conditions were not optimized to promote the survival of GABAergic neurons.
Future studies will be necessary to more conclusively determine whether the glutamatergic phenotype represents a default state generated by Ascl1, Brn2 and Myt1l during the reprogramming process or instructed by the reprogramming factors. In light of these data, it is worth noting that Brn2 is expressed during cortical development in progenitors that give rise to glutamatergic neurons in layers II/III and V 160, 197 . Loss of Brn1 and Brn2 disrupts migration of upper-layer neurons in the cortex and disrupts proliferation of cortical progenitors in the VZ and SVZ after E14. 5 (refs. 198,199) . Given that Ascl1 and Myt1l are both expressed in neurons with a variety of different neurotransmitter phenotypes, the putative role of Brn2 in regulating differentiation of subpopulations of glutamatergic cortical neurons could explain the glutamatergic phenotype of iN cells generated by Brn2, Ascl1 and Myt1l. Further studies in Brn1/Brn2 knockout mice will be necessary to determine the roles of these genes in the specification of a glutamatergic neurotransmitter phenotype during cortical development 160 . In this regard, it will also be important to determine the expression patterns of additional cortical layer-specific subtype markers in iN cells. These studies should provide insight into future attempts to generate other specific types of neurons directly from fibroblasts.
Surprisingly, the generation of iN cells was rapid, with the first neuronal markers detected as early as 3 days after induction of the viral transgenes, and reached efficiencies of nearly 20% after 2 weeks. The reprogramming process could also occur in the absence of cell division, similar to lineage reprogramming in other cell types 36, 39 , and was not dependent on continued expression of the exogenous reprogramming factors (unpublished data). Although this work provides an important proof of concept that neurons can be derived from readily available dermal fibroblasts, the exact cell of origin has not been determined. Even though RT-PCR analysis detected expression of one neural crest marker in the tail tip cultures, several observations argue against the possibility that the majority of iN cells were derived from infected neural crest cells. First, neural crest stem cells were not present in the cultures because even in permissive conditions no neurons were detected. Second, iN cells had a central nervous system phenotype. If neural crest cells were infected with the reprogramming factors, one would expect the generation of peripheral neurons. Finally, it is highly unlikely that 20% of the cells in the cultures were derived from neural crest cells. To ultimately clarify this important question, future lineage-tracing studies will be critical to demonstrate that iN cells can be derived from mesodermal fibroblasts or from other defined somatic cell types. Gene expression patterns and chromatin modifications on a genome-wide scale will then determine whether the transcriptional program of the donor cell type is silenced. These data would allow for a more thorough evaluation of the fidelity of reprogramming.
More recently, our group 30 and another laboratory 201 have found that synaptically competent iN cells can also be generated from human fibroblasts using a similar combination of genes. The conversion of human fibroblasts to fully functional iN cells appears to be greatly aided by the addition of the basic helix-loop-helix transcription factors Neurod1 or NEUROD2. The NeuroD family of transcription factors are basic helix-loop-helix proneural genes thought to function downstream of Ngn1, Ngn2 and Ascl1 during neuronal differentiation, somewhat analogous to Myod1 and Myog in skeletal muscle 146, 165 . Notably, forced expression of Neurod1 and Brn2 in human fibroblasts was sufficient to generate TUJ1-postive neuronal cells, although their functional development appears delayed compared with cells infected with all four factors. Furthermore, the two neuronal specific micro-RNAs miR-9* and miR-124 seem to replace the function of Brn2 in the context of the other three transcription factors 201 . Surprisingly, miR-9/9* and miR-124 were sufficient to induce cells with immature bipolar neuronal morphologies at low frequency. Brn2, on the other hand, is not sufficient to induce any neuronal traits 29, 30 . Given that Neurod1 can partially replace Ngn3 during in vivo exocrine-to-endocrine reprogramming in the pancreas (see above), it will be interesting to perform more thorough structure-function studies of these factors to elucidate their shared and unique functions during reprogramming in the context of neuronal and pancreatic tissues.
Two recent studies have reported that the addition of transcription factors that are involved in dopaminergic neuronal development can generate iN cells from mouse and human fibroblasts that express tyrosine hydroxylase and release dopamine; however, it is not clear whether these cells are mature enough to form synapses 200, 202 . Interestingly, each study used a distinct group of transcription factors for conversion (Brn2, Ascl1, Myt1l plus Lmx1a and Foxa2 versus Ascl1, Nurr1 and Lmx1a).
In general, compared with mouse iN cells, human iN cells appear to be less functionally mature, are generated at 3-to 5-fold lower efficiency and require longer periods of time to develop active membrane properties and to form synapses. Further optimization of the transcription factor combinations used for reprogramming and the neuronal culture conditions may improve the generation and functional maturation of human iN cells.
Another critical area of future investigation will be to determine how Brn2 and Myt1l collaborate with Ascl1 to induce neuronal differentiation from fibroblasts. Functional synergy between proneural basic helix-loop-helix proteins and Myt family proteins has been described during Xenopus laevis neuronal differentiation and during endocrine cell differentiation in the mouse pancreas 167, 203 . Myt1l is a CCHC domain-containing zinc-finger transcription factor that is expressed throughout the central and peripheral nervous systems in differentiating neurons as they become post-mitotic 204, 205 , whereas r e v i e w the closely related Myt1 is expressed in proliferating neural progenitors, oligodendrocyte-progenitor cells and differentiating neurons 206 . In Xenopus, forced expression of the proneural basic helix-loop-helix transcription factor X-Ngnr1 is sufficient to induce ectopic neurogenesis throughout the ectoderm, even in the absence of neural induction 167 . This ectopic neurogenesis often occurs without cell division, providing strong evidence that these cells are generated by direct conversion of prospective epidermal and neural crest cells into neurons, analogous to neural lineage reprogramming studies in mammalian cells in vitro. Xenopus Myt1 was required for ectopic neurogenesis induced by X-Ngnr1. Whether this synergy is conserved during neuronal differentiation in mammals is currently unclear.
During pancreatic endocrine cell differentiation in mice, Myt1 and Ngn3 appear to form a feed-forward transcriptional circuit that helps to promote endocrine fate 203 . Myt1 is expressed in both the endocrine progenitors and terminally differentiated endocrine cells and functions primarily as a transcriptional activator in this context 207 . Thus, Myt family proteins seem to be critical and conserved regulators of proneural transcription factor activity during neuronal differentiation in vertebrates. However, further studies will be necessary to determine the exact functions of Myt proteins during mammalian neural development.
In mice, Brn2 is broadly coexpressed with Ascl1 in the ventricular and subventricular zones of the spinal cord and ventral telencephalon, where it synergistically regulates transcription of the Delta1 gene, as well as other critical regulators of notch signaling (e.g., Dll1, Jag2 and Lfng), indicating that it might cooperate with Ascl1 to regulate neuronal differentiation 208 . Similarly, in the chick neural tube, electroporation of Brn2 causes neural progenitors to exit the cell cycle and differentiate into neurons 208 . Studies in Xenopus have also shown that XIPOU2 (homologous to mammalian Brn4) is a downstream target of noggin (Nog) during neural induction and is also sufficient to drive neuronal differentiation in uncommitted ectodermal tissue 209 . These studies should inform future efforts to understand the mechanism of action of these factors during the reprogramming process.
Common features of different somatic lineage conversions
A comparison of the direct lineage conversion experiments published to date reveals several common themes, despite the differences in cell types involved. First, in almost all cases, the reprogramming factors identified were transcription factors. It is conceivable that other classes of factors, such as components of chromatin modifying complexes, microRNAs and other RNA species, signaling pathway modulators or small molecules, may also be sufficient to induce lineage conversion (and some examples have indeed been demonstrated 41, 97, [210] [211] [212] [213] [214] ). The predominance of transcription factors in reprogramming experiments should not be surprising given that they are the primary effectors of lineage decisions during normal development.
Modulation of signaling pathways would be an attractive alternative to transcription factors because lineage conversion could be achieved without genetic modification. Considering the limited number of signaling pathways compared with the vast number of somatic cell types, it seems unlikely that combinations of existing signaling pathways would be sufficient to induce specific cell fates outside the context of the developing embryo. Similarly, cellular responses to growth factors and other extracellular signaling molecules are limited by the repertoire of receptors present on the starting cell type. Furthermore, receptor-exchange experiments have suggested the limits of receptor specificities. For instance, lymphoid cell lines have been engineered to express the muscarinic acid receptor in place of the T-cell receptor 215 . Remarkably, the stimulation of the muscarinic acid receptor induced immune gene transcriptional responses. Similarly, stimulation of platelet-derived growth factor and fibroblast growth factor receptors induces almost identical transcriptional responses in fibroblasts 216 . Thus, it is possible that modulation of signaling pathways is able to induce transdetermination (as described for the blood lineage 97 ) but would be insufficient to induce conversion between more distantly related lineages. Specific signaling pathways ultimately act by altering the transcription of downstream genes, but these outcomes are highly context specific, as illustrated by the repeated utilization of the same signaling pathways for diverse outcomes during different stages of development. Forced expression of lineage-specific transcription factors would thus be more likely to be sufficient to activate the necessary regulatory networks for generating distinct cellular fates de novo 217 .
Another striking theme from these studies is that lineage conversion often appears to take place without the generation of an intermediate progenitor cell type 29, 39, 42 . This conclusion is compatible with the notion that transcription factor-mediated lineage reprogramming is a direct phenotypic conversion between two distinct cell types and not a dedifferentiation process followed by differentiation to an alternative fate. This suggests that some lineage-determining transcription factors might be capable of modulating expression of their physiological targets independent of the pre-existing chromatin context, thus acting as 'pioneer' factors during the reprogramming process 82 .
Equally surprising is the fact that many direct cell fate conversion examples do not require cell division 29, 39, 108 . In dividing cells, unmodified histones are incorporated into DNA during S-phase, perhaps making them more prone to epigenetic flexibility than postmitotic cells 218 . In line with this notion is the finding that cell proliferation is required for the generation of iPS cells 219 . Modulation of cell cycle regulators such as p53, p16 and p19 also dramatically increases the efficiency of iPS cell reprogramming [220] [221] [222] [223] [224] . Nonetheless, mice have been cloned from the nuclei of post-mitotic olfactory neurons, and heterokaryons between mouse embryonic stem (ES) cells and human fibroblasts exhibit rapid activation of pluripotency markers without undergoing cell division 8, 9, 225 . Finally, compared with iPS cell reprogramming, somatic lineage conversions are very rapid, with the first marker genes of the target lineage being expressed hours to days after gene induction 29, 42, 108 . This is consistent with the fact that no cell division is required and that the conversion efficiencies are at least an order of magnitude higher than those of iPS cell reprogramming 29, 108, 226, 227 . How the genome-wide chromatin remodeling that is presumably associated with somatic lineage conversion can be accomplished without cell division is completely obscure, and will likely be a critical area of future investigation.
Possible mechanisms and open questions
Perhaps one of the most fascinating questions arising from direct lineage conversion studies is how a handful of transcription factors can induce such dramatic genome-wide transcriptional and epigenetic changes (Fig. 3) . The activity of transcription factors was one of the first proposed mechanisms of gene regulation many decades ago 228, 229 . Since the exciting discoveries of various chromatin marks and associated remodeling factors over the last 15 years or so, epigenetic modifications have largely dominated the general view of how eukaryotic genomes are transcriptionally regulated 230, 231 . The recent reprogramming studies have reminded the field about the power of transcription factors and have reinforced the notion that both mechanisms are important contributors to eukaryotic gene regulation. Some of these chromatin modifications, for example, DNA methylation, are considered stable and heritable 232 . However, DNA methylation could be more dynamic and flexible than previously appreciated 225, 233 . r e v i e w Some general rules apply for lineage conversion: (i) the process is initiated with high levels of ectopic transcription factors, (ii) the activation of early lineage reporters is fast, (iii) reprogramming can occur without cell division and (iv) the activation of markers of mature cells and the acquisition of functional properties are generally delayed. Thus, the most appealing model is that the ectopic transcription factors are upstream of the subsequent chromatin remodeling and act as 'pioneer' transcription factors, that is, factors that can activate target genes in a repressed chromatin state 82, 234 (Fig. 3a) . We speculate that chromatin modifications are dynamic, fluctuating between the repressive and partially active configuration 230 . At silenced loci the majority of marks are repressive at any given time (Fig. 3b) . When the reprogramming transcription factors (Fig. 3c) are introduced, they may weakly bind to the subset of randomly accessible sites in a promoter (green in Fig. 3c ). This initially weak interaction may then interfere with the random fluctuation and stabilize active configurations. With accumulating accessible sites, more and more transcription factors could be recruited, which would eventually lead to active transcription of that locus. Loci coding for transcription factors could further enhance activation of target genes by positive feedback and feed-forward loops (Fig. 3d) .
In some cases, different combinations of transcription factors can drive the same cell fate conversion process (e.g., ref. 29) . This suggests a model in which many (if not all) of the key upstream transcription factors regulate one another. Thus, rather than one 'master' transcription factor, there seems to be a group of master transcription factors that can be induced by various subsets of the component genes. Once activated, they would regulate each other in a self-organizing network and execute the downstream lineage-differentiation program, resulting in the concerted induction of the various structural proteins required for the function of the particular differentiated cell type 78, 217, 235, 236 . The closer the reprogramming factor combination is to this master regulatory network, the more efficient and accurate the reprogramming would be, although smaller subsets are often sufficient to initiate reprogramming 42 . Once the endogenous self-maintaining network is activated, the exogenous transcription factors should become dispensable, which would explain why the reprogrammed state tends to be stable in the absence of the exogenous reprogramming factors.
Somewhat puzzling is the observation that many genes characteristic of the donor cell type are rapidly downregulated, even before the target program is activated 108, 237, 238 . Similarly, the fact that the same transcription factors can induce one cell type from many different donor cell types and thus downregulate many different host cell transcriptional programs seems counterintuitive 37, 227, 239, 240 . A possible explanation for this phenomenon is that the high levels of exogenous transcription factors simply saturate the transcriptional and translational machinery of the cell and thus actively outcompete the original transcriptional program. A similar mechanism has been proposed to regulate the switch between neurogenesis and gliogenesis from multipotent neural stem cells, where the basic helix-loop-helix transcription factor Ngn1 interacts with p300 and sequesters it away from the promoters of genes important for gliogenesis 241 . Alternatively, there may be a general binary switch once a novel cell fate is induced that causes the pre-existing transcriptional program to collapse.
Surprisingly, temporally regulated expression of the reprogramming factors does not have to precisely mimic the temporal expression patterns of the corresponding endogenous factors. This suggests that these transcriptional networks are highly robust, resulting in the same outcome despite different levels and timing of expression of their component genes 242 . Furthermore, constitutive expression does not appear to significantly affect the induction and maintenance of the endogenous transcriptional networks, suggesting that post-transcriptional regulation, such as microRNA-mediated degradation or post-translational modifications of the transcription factors within the network, is involved.
Finally, it remains to be seen whether in direct somatic lineage conversions the reprogramming is truly complete, or whether any epigenetic memory of the previous cell fate remains, as has been seen with nuclear transfer 243, 244 and iPS cells 245, 246 . It will also be interesting to compare induced cell types originating from different donor cell types and to determine the impact of donor cell type on reprogramming efficiency and fidelity. Box 1 provides a summary of important unresolved issues in the field. In principle, these applications are similar to those envisioned for iPS cells (e.g., for reviews, see refs. [247] [248] [249] , but each approach has its own advantages and disadvantages relative to the other. Below, we discuss various aspects of these three classes of applications and compare direct lineage conversion to iPS cell-based approaches. Table 2 provides a general comparison. In contrast to differentiation of iPS or ES cells driven by signaling molecules and growth factors, direct lineage conversion provides a new approach to study the activity of transcription factors. The classic way to analyze gene function is by introduction of mutations and gain-or loss-of-function experiments. Typically these perturbations are analyzed in a physiological context, such as the phenotypic analysis of a knockout mouse strain or the ectopic expression of gene products in related compartments (e.g., in various regions of the developing neural tube [250] [251] [252] ). Transcription factor-mediated direct lineage conversion allows the study of a transcription factor outside its normal and physiological context. For example, based on the current literature, it was somewhat unexpected that iN cells generated by transcription factor combinations containing Ascl1 produced exclusively excitatory neuronal subtypes 29 . Ascl1 is highly associated with the generation of inhibitory neurons and can cause expression of ventral markers when expressed in the dorsal telencephalon 176 . Because a large number of transcription factors can be tested in different cellular contexts, direct lineage conversion studies may facilitate the characterization of common transcription factor networks or the identification of novel mechanisms for restricting the activity of a transcription factor to a specific context 253, 254 .
This approach has already been elegantly applied to investigate the context-specific activity of ectopically expressed transcription factors in Caenorhabditis elegans. By generating worms that express the sensory neuron-specific transcription factor CHE-1 in every tissue, Hobert and colleagues 211 were able to perform an RNA interference screen of all known chromatin-associated proteins to find genes that are important for limiting the activity of CHE-1 to sensory neurons. They found that lin-53 knockdown allowed CHE-1 (and other neuronal subtype-specific transcription factors) to convert mitotic germ cells into neurons in vivo. Lin-53 (RBAP46/48 in humans) is a histone chaperone that plays a role in numerous chromatin-remodeling and silencing complexes. This effect could be phenocopied by treating the worms with the histone deacetylase inhibitors valproic acid and trichostatin. Furthermore, the authors provided preliminary evidence that the effect was specific to the neuronal transcription factors tested, as lin-53 loss did not promote conversion of mitotic germ cells to myocytes after forced expression of the C. elegans MyoD homolog hlh-1. The use of model organisms to perform in vivo short hairpin RNA screens should continue to provide important insight into the chromatin regulatory processes that permit and prevent transcription factors from being active in diverse cellular contexts.
Like the differentiation of pluripotent stem cells to specific cell types, direct lineage conversion provides a simple tool for studying developmental processes in vitro [255] [256] [257] . Such accessible culture systems can be used to search for novel cell fate determinants by candidate gene approaches and with unbiased genomic screens. Although ES and iPS cell differentiation is preferable for studying early developmental processes (such as neural induction), the strength of the direct lineage reprogramming approach may lie in studying terminal differentiation and maturation, as well as the acquisition of functional properties, processes which are relatively poorly understood, especially in the nervous system. The combination of pluripotent stem cell differentiation and direct lineage reprogramming provides a powerful tool kit for studying the development of a variety of cell types in vitro. The use of human cells also allows the study of human developmental processes that may differ in important ways from those of rodents 30, 257, 258 . However, the similarity of such in vitro processes to normal in vivo development remains unclear, and it will be critical to evaluate specific genes of interest in both contexts to determine their physiological relevance.
Box 1 Broad questions in direct lineage conversion experiments
Work demonstrating the ability to several different somatic cell types to convert into other cell types in the presence of combinations of exogenous reprogramming factors raises several questions regarding lineage determination and cell specialization. A selection of these are provided below:
• How can transcription factors find their relevant binding sites in a cell type that has a different pattern of chromatin modifications than the factors normally encounter? r e v i e w Perhaps the most exciting future application of these novel tools is the possibility of greater access to human cells of diverse types. Only a few examples of direct reprogramming of human somatic cells have been reported 30, 43, [200] [201] [202] , but many are likely forthcoming in the near future. For example, the major reason for our limited understanding of many human brain disorders is arguably the lack of human neurons suitable for experimentation. The development of iPS cell technologies has provided the first method to generate patient-derived cells, but these approaches have certain limitations that may be circumvented by using direct lineage reprogramming (summarized in Table 2 ). Although iPS cells have the clear advantage of unlimited growth, making them amenable for use in highthroughput assays, it is technically very challenging to produce iPS cell lines from numerous individuals. With direct lineage converted cells, unless a proliferative intermediate can be induced, scale up as fibroblasts or other cells types before reprogramming is required. However, as lineage reprogramming is fast and efficient, the screening of dozens or even hundreds of individuals may become feasible as conversion methods are refined.
Despite major recent breakthroughs, the differentiation of human ES and iPS cells is highly variable, cell-line dependent and generates immature (or in some cases fetal-stage) cells that differ from those found in mature organs in vivo 259 . For the neural lineage, current protocols often do not produce homogenous neuronal subtypes, and differentiated neurons tend to be functionally immature [260] [261] [262] [263] . Lineage reprogramming may offer the possibility to produce more homogenous cell populations, at least with regard to reproducibility and subtype generation 29 , although a direct comparison of ES or iPS-derived cells and cells generated by direct conversion has not yet been performed.
Despite these challenges, several recent studies have reported the successful recapitulation of disease phenotypes in differentiated iPS cells from individuals with monogenetic diseases. Studer and colleagues 264 have generated iPS cells from patients with familial dysautonomia, a rare disorder most frequently caused by a point mutation in the IKBKAP gene that results in peripheral and autonomic neuronal degeneration. After differentiation into neural crest progenitor cells, patient-derived cells exhibited decreased levels of IKBKAP transcripts as well as migration defects, providing a possible explanation for the pathogenesis of the disease and a platform for the identification of disease-modifying agents. In other studies, Gage and colleagues 265,266 generated iPS cells from patients with Rett syndrome and schizophrenia. Rett syndrome is caused by mutations in the X-linked MECP2 gene and is a neurodevelopmental disorder affecting female children. In both Rett syndrome and schizophrenia, patient iPS cell-derived neurons exhibited several differences in synaptic function compared with neurons derived from wild-type iPS cells. The schizophrenia study is particularly exciting as it provides some initial insight into a complex genetic disorder. Furthermore, iPS cell-based models of human neurodegenerative disorders, such as genetic Parkinson's disease, are also being developed 267 .
Cardiovascular disorders have also been modeled in vitro using patient-derived iPS cells. LEOPARD syndrome is caused by dominant mutations in genes involved in ras signaling and is characterized by various malformations, including hypertrophic cardiomyopathy 268 . LEOPARD patient-derived cardiomyocytes generated from iPS cells showed various signaling abnormalities and were larger than control cells from an unaffected sibling. Another study described iPS cells from individuals with mutations in L-type Ca 2+ channels that cause long QT syndrome 269 . iPS cell-derived ventricular cardiomyocytes showed several electrophysiological abnormalities that could explain the pathological cardiac conductive system.
Finally, induced somatic cells could be used for autologous therapeutic cell transplantation. Again, iPS cells offer the advantage of scalability but can form teratomas when not properly differentiated. Directly induced somatic cells, on the other hand, would bypass the pluripotent state and thus would presumably be less tumorigenic, provided integration-free gene delivery methods are applied 270, 271 . Another interesting potential application of direct lineage reprogramming would be the use of the reprogramming factors directly in vivo 33 . Although limited by the well-known complications associated with in vivo gene delivery, this approach would eliminate the lengthy process of culturing explanted cells for lineage conversion. Such approaches may be interesting to explore for myocardial infarction, diabetes and neurodegenerative disorders such as Parkinson's disease. 
